Amanta Healthcare reported Q4 FY26 revenue of INR77 crore and a 28% YoY PAT increase to INR5.5 crore, with full-year revenue at INR288 crore.
The company is expanding SteriPort IV fluid capacity from 6.6 crore to 12 crore bottles annually, with commissioning targeted for June 20, 2026.
Management addressed a 60-70% raw material price increase, confirming full pass-through to customers with no expected gross margin impact.
A 10.8 MW captive solar project is set for commissioning by end-May 2026, expected to save INR75 lakh per month in power costs.